a month ago
JAZZ
AnalystsJoon LeeJoon Lee's Stock Forecasts
AnalystsJoon Lee
Sectors:
Analyst Ranking
Top 2%
#73 out of 5192 analysts
Average Return
+43.09%
Win Rate
61%80 out of 132
Risk vs Reward
Poor
Good
Joon Lee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +845.60% | $33.55 | $317.25 | 2025-03-03 - 2026-02-13 | Strong Buy |
Verona Pharma PLCVRNA | +548.82% | $14.46 | $93.82 | 2024-06-28 - 2025-06-27 | Strong Buy |
Viking Therapeutics IncVKTX | +470.38% | $10.87 | $62.00 | 2023-10-02 - 2024-10-01 | Strong Buy |
Intellia Therapeutics IncNTLA | +418.87% | $25.44 | $132.00 | 2020-10-27 - 2021-10-26 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-29 - 2024-03-28 | Strong Buy |
Joon Lee Analyst Color
Get additional color on Joon Lee's coverage of popular stocks
2 months ago
BMRN
2 months ago
WVE
2 months ago
PRAX
3 months ago
ALKS
4 months ago
BMRN
4 months ago
PRAX
5 months ago
ARGX
6 months ago
JAZZ
7 months ago
PTCT
a year ago
CORT
a year ago
AXSM
a year ago
CRSP
a year ago
AXSM
a year ago
ARGX
a year ago
AXSM
a year ago
VRNA
a year ago
WVE
a year ago
CPRX
a year ago
ARGX
a year ago
CRMD
a year ago
VRNA
a year ago
CORT
2 years ago
CPRX
2 years ago
ARGX
Joon Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Jazz Pharmaceuticals PLCJAZZ | 4 | Strong Buy | $230.00 | +38.30% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $100.00 | +67.03% | Maintains | 2 months ago |
Wave Life Sciences LtdWVE | 4 | Strong Buy | $50.00 | +294.32% | Maintains | 2 months ago |
Praxis Precision Medicines IncPRAX | 7 | Strong Buy | $500.00 | +57.60% | Maintains | 2 months ago |
Alkermes PLCALKS | 3 | Strong Buy | $55.00 | +65.86% | Maintains | 3 months ago |
Intellia Therapeutics IncNTLA | 5 | Strong Buy | $14.00 | +17.94% | Reiterates | 3 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $90.00 | +338.60% | Maintains | 3 months ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $44.00 | +57.54% | Initiates Coverage On | 5 months ago |
Argenx SeARGX | 13 | Strong Buy | $918.00 | +11.68% | Maintains | 5 months ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $490.00 | -0.30% | Maintains | 6 months ago |
Ptc Therapeutics IncPTCT | 2 | Strong Buy | $86.00 | +23.83% | Maintains | 7 months ago |
Sage Therapeutics IncSAGE | 8 | Hold | $9.00 | +3.69% | Maintains | 8 months ago |
Viking Therapeutics IncVKTX | 8 | Strong Buy | $75.00 | +158.62% | Reiterates | 10 months ago |
Arvinas IncARVN | 6 | Strong Buy | $21.00 | +80.26% | Maintains | 10 months ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $150.00 | +275.28% | Maintains | a year ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $200.00 | +10.37% | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 5 | Strong Buy | $120.00 | N/A | Maintains | a year ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Verona Pharma PLCVRNA | 6 | Strong Buy | $57.00 | N/A | Reiterates | a year ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $36.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 7 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Cormedix IncCRMD | 6 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 2 | Hold | $60.00 | N/A | Downgrades | a year ago |
Adverum Biotechnologies IncADVM | 6 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 7 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Taysha Gene Therapies IncTSHA | 7 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Concert Pharmaceuticals IncCNCE | 2 | Strong Buy | $25.00 | N/A | Maintains | 3 years ago |
Aptinyx IncAPTX | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Cyclerion Therapeutics IncCYCN | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $50.00 | N/A | Upgrades | 5 years ago |
Translate Bio IncTBIO1 | 2 | Hold | $360.00 | N/A | Downgrades | 5 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $34.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.